
FSD Pharma (HUGE) P/E Ratio
P/E Ratio as of Aug 7, 2025: -1.76
Average-1.51
Median-1.53
Minimum-1.88
Maximum-1.12
-1.76
Past Month-0.61 (53.04%)
The P/E ratio for FSD Pharma (HUGE) is -1.76 as of Aug 7, 2025. This represents a increase of 203.45% compared to its 12-month average P/E ratio of -0.58. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
FSD Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
FSD Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing FSD Pharma to industry peers.
FSD Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
FSD Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing FSD Pharma to industry peers.
FSD Pharma (HUGE) P/E Ratio Insights
See FSD Pharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in FSD Pharma (HUGE)
Order type
Buy in
Order amount
Est. shares
0 shares
FSD Pharma (HUGE) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Aug 1, 2025 | $23.70 | -1.60 |
Jul 1, 2025 | $19.32 | -1.30 |
Jun 2, 2025 | $15.20 | -1.03 |
May 1, 2025 | $6.80 | -0.47 |
Apr 1, 2025 | $7.99 | -0.55 |
Mar 3, 2025 | $4.295 | -0.29 |
Feb 3, 2025 | $3.18 | -0.21 |
Jan 2, 2025 | $4.08 | -0.27 |
FSD Pharma (HUGE) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -1.76 | +604.00% |
2024 | -0.25 | -84.08% |
2023 | -1.57 | +21.71% |
2022 | -1.29 | +32.99% |
2021 | -0.97 | +83.02% |
2020 | -0.53 | — |
FAQs About FSD Pharma (HUGE) P/E ratio
The latest P/E ratio of FSD Pharma (HUGE) is -1.76, as of Aug 7, 2025. This is calculated based on its current stock price and earnings per share (EPS).
FSD Pharma’s last 12-month average P/E ratio is -0.58, compared to its current P/E ratio of -1.76. This reflects a increase of 203.45%.
FSD Pharma’s current P/E ratio of -1.76 is higher than its last 12-month average P/E of -0.58. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
FSD Pharma’s average P/E ratio over the last 3 years is -1.3. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
FSD Pharma’s average P/E ratio over the last 5 years is -1.14. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.